• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LKB1 参与人肺癌细胞上皮-间充质转化(EMT)。

Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.

机构信息

Biology Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Lung Cancer. 2010 Nov;70(2):136-45. doi: 10.1016/j.lungcan.2010.02.004. Epub 2010 Mar 5.

DOI:10.1016/j.lungcan.2010.02.004
PMID:20207041
Abstract

Epithelial-mesenchymal transition (EMT) is a critical phenotypic alteration of cancer cells that triggers invasion and metastasis. Lung cancer cells often show mesenchymal phenotypes; however, a causative genetic alteration for the induction of EMT in lung cancer cells remains unknown. Recent studies have shown that the LKB1 gene is mutated in up to one-third of lung adenocarcinomas. Therefore, to pursue the possible involvement of LKB1 inactivation in the induction of EMT in lung carcinogenesis, we generated immortalized lung epithelial cells and lung adenocarcinoma cells with stable or transient LKB1 knockdown. LKB1 knockdown increased cell motility and invasiveness, and induced the expression of several mesenchymal marker proteins accompanied by the expression of ZEB1, a transcriptional repressor for E-cadherin and an EMT inducer. In agreement with the recent findings, expression of miR-200a/c was inversely correlated with that of ZEB1 in LKB1 knockdown clones with mesenchymal phenotype. Furthermore, transient knockdown of LKB1 induced ZEB1 mRNA and increased cell motility, and this motility was suppressed by ZEB1 repression. These results strongly indicate that LKB1 inactivation triggers EMT in lung cancer cells through the induction of ZEB1.

摘要

上皮-间充质转化(EMT)是癌症细胞的一种关键表型改变,可触发侵袭和转移。肺癌细胞常表现出间充质表型;然而,肺癌细胞中 EMT 诱导的致病变异仍不清楚。最近的研究表明,LKB1 基因在多达三分之一的肺腺癌中发生突变。因此,为了探讨 LKB1 失活在肺肿瘤发生中诱导 EMT 中的可能参与,我们生成了稳定或瞬时敲低 LKB1 的永生化肺上皮细胞和肺腺癌细胞。LKB1 敲低增加了细胞迁移和侵袭性,并诱导了几个间充质标记蛋白的表达,同时表达了 ZEB1,它是 E-钙粘蛋白的转录抑制因子和 EMT 诱导因子。与最近的发现一致,在具有间充质表型的 LKB1 敲低克隆中,miR-200a/c 的表达与 ZEB1 的表达呈负相关。此外,瞬时敲低 LKB1 诱导 ZEB1 mRNA 的表达并增加细胞迁移性,而这种迁移性被 ZEB1 抑制所抑制。这些结果强烈表明,LKB1 失活通过诱导 ZEB1 触发肺癌细胞中的 EMT。

相似文献

1
Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.LKB1 参与人肺癌细胞上皮-间充质转化(EMT)。
Lung Cancer. 2010 Nov;70(2):136-45. doi: 10.1016/j.lungcan.2010.02.004. Epub 2010 Mar 5.
2
Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.下调的 microRNA-200a 通过靶向胃腺癌中的 E-钙黏蛋白抑制剂 ZEB1/ZEB2,通过 wnt/β-连环蛋白通路促进 EMT 和肿瘤生长。
Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.
3
Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.微小RNA-101缺失促进肝细胞上皮-间质转化
J Cell Physiol. 2015 Nov;230(11):2706-17. doi: 10.1002/jcp.24995.
4
Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.LKB1-SIK1信号通路减弱促进非小细胞肺癌细胞的上皮-间质转化和放射抗性。
Chin J Cancer. 2016 Jun 7;35:50. doi: 10.1186/s40880-016-0113-3.
5
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.BCL6 通过促进 ZEB1 介导的 E-钙黏蛋白转录抑制在乳腺癌细胞中诱导 EMT。
Cancer Lett. 2015 Sep 1;365(2):190-200. doi: 10.1016/j.canlet.2015.05.029. Epub 2015 Jun 3.
6
Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.抑制ZEB1可逆转多西他赛耐药的人肺腺癌细胞系中的上皮-间质转化及化疗耐药性。
J Cell Biochem. 2013 Jun;114(6):1395-403. doi: 10.1002/jcb.24481.
7
Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.遗传和药理学抑制 mTORC1 通过 TGF-β 非依赖机制促进 EMT。
Cancer Res. 2013 Nov 15;73(22):6621-31. doi: 10.1158/0008-5472.CAN-13-0560. Epub 2013 Sep 27.
8
MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.微小RNA-652通过靶向锌指E盒结合蛋白1抑制酸性微环境诱导的胰腺癌细胞上皮-间质转化。
Oncotarget. 2015 Nov 24;6(37):39661-75. doi: 10.18632/oncotarget.5350.
9
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.miR-200家族通过直接靶向E-钙黏蛋白转录抑制因子ZEB1和ZEB2来抑制上皮-间质转化和癌细胞迁移。
J Biol Chem. 2008 May 30;283(22):14910-4. doi: 10.1074/jbc.C800074200. Epub 2008 Apr 14.
10
Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.蛋白酶体抑制剂耐药细胞通过miR-200和ZEB1抑制E-钙黏蛋白来诱导上皮-间质转化。
Int J Oncol. 2015 May;46(5):2251-60. doi: 10.3892/ijo.2015.2916. Epub 2015 Mar 4.

引用本文的文献

1
Pan-Cancer Computational Analysis of RKIP () and LKB1 () Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment.RKIP()和LKB1()共表达的泛癌计算分析突出了肿瘤微环境中不同的免疫代谢动态和治疗反应。
Int J Mol Sci. 2025 Jul 24;26(15):7145. doi: 10.3390/ijms26157145.
2
Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma.嘧啶代谢重塑免疫微环境并提示胶质瘤预后不良。
Clin Transl Oncol. 2025 May;27(5):2127-2142. doi: 10.1007/s12094-024-03753-5. Epub 2024 Oct 16.
3
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy.
AXL 表达反映了影响免疫检查点抑制剂单药治疗的非小细胞肺癌患者结局的肿瘤免疫细胞动态。
Front Immunol. 2024 Aug 21;15:1444007. doi: 10.3389/fimmu.2024.1444007. eCollection 2024.
4
LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer.LKB1缺失与STING缺失相关,并且与β-连环蛋白膜性缺失共同作用,提示可手术切除的非小细胞肺癌患者预后不良。
Cancers (Basel). 2024 May 10;16(10):1818. doi: 10.3390/cancers16101818.
5
Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.冬凌草甲素通过正向调节LKB1/AMPK信号通路抑制喉癌的上皮-间质转化。
Int J Med Sci. 2024 Jan 21;21(4):623-632. doi: 10.7150/ijms.92182. eCollection 2024.
6
Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.罗氟司特抑制STK11/LKB1缺陷型胰腺癌的肿瘤生长和迁移。
Cell Death Discov. 2024 Mar 9;10(1):124. doi: 10.1038/s41420-024-01890-y.
7
LKB1 depletion-mediated epithelial-mesenchymal transition induces fibroblast activation in lung fibrosis.LKB1缺失介导的上皮-间质转化在肺纤维化中诱导成纤维细胞活化。
Genes Dis. 2024 May;11(3):101065. doi: 10.1016/j.gendis.2023.06.034.
8
MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy.肺腺癌中的 miRNAs:作用、诊断、预后和治疗。
Int J Mol Sci. 2023 Aug 27;24(17):13302. doi: 10.3390/ijms241713302.
9
STK11 mutation impacts CD1E expression to regulate the differentiation of macrophages in lung adenocarcinoma.STK11 突变影响 CD1E 的表达,从而调节肺腺癌中巨噬细胞的分化。
Immun Inflamm Dis. 2023 Jul;11(7):e958. doi: 10.1002/iid3.958.
10
Downregulation of a tumor suppressor gene LKB1 in lung transplantation as a biomarker for chronic murine lung allograft rejection.下调抑癌基因 LKB1 作为肺移植慢性排斥反应生物标志物在小鼠肺移植中的作用
Cell Immunol. 2023 Apr;386:104690. doi: 10.1016/j.cellimm.2023.104690. Epub 2023 Feb 16.